Supported by an educational grant from Merck
TITLE - Personalized Care in Colorectal Cancer: Targeted Therapy & Biomarkers
TARGET AUDIENCE - Target audiences for this program are Specialty Pharmacists, Pharmacists, Clinical Pharmacists, Specialty Pharmacy executives, Pharmacy Directors, Chief Pharmacy Officers, Oncology Pharmacists, Oncology Nurses, and Nurses
LEARNING OBJECTIVES - After completing the program, Specialty Pharmacists, Pharmacists, Clinical Pharmacists, Specialty Pharmacy executives, Pharmacy Directors, Chief Pharmacy Officers, Oncology Pharmacists, Oncology Nurses, and Nurses
- Discuss effective strategies for prevention and control of colorectal cancer (CRC)
- Recognize common locations of CRC metastases and list symptoms associated with specific sites
- Describe best practices for molecular screening and the importance of novel biomarkers in CRC
- Identify subtypes and biomarkers in CRC and understand how these may impact treatment selection and/or prognosis
- Identify an individualized treatment plan based on tumor profile, biomarker analysis, and patient characteristics
- Identify barriers to adherence and persistence and understand how to anticipate and overcome those barriers
Before the activity, all faculty and anyone who is in a position to have control over the content of this activity and their spouse/life partner will disclose the existence of any financial interest and/or relationship(s) they might have with any commercial interest producing healthcare goods/ services to be discussed during their presentation(s): honoraria, expenses, grants, consulting roles, speakers bureau membership, stock ownership, or other special relationships. Presenters will inform participants of any off-label discussions. All identified conflicts of interest are thoroughly vetted by the Specialty Pharma Education Center for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.
Faculty Disclosure: Damary Torres, PharmD, has no relevant conflicts of interest to disclose. She does intend to discuss non-FDA approved drugs or investigational use of any product/device.
Pharmacist continuing education credit
Specialty Pharma Education Center (SPEC) is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This program is approved for 1.5 hours (0.15CEUs) of continuing pharmacy education credit. Proof of participation will be posted to your NABP CPE profile within 4 to 6 weeks to participants who have successfully completed the post-test (score of 70% or higher). Participants will have 3 opportunities to pass the post-test. Participants must participate in the entire presentation and complete the course evaluation to receive continuing pharmacy education credit.
Knowledge Based Activity
Course release date 9/16/2020
Course expires 9/16/2023
Nursing continuing education credit
Educational Review Systems is an approved provider of continuing nursing education by the Alabama State Nursing Association, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation. Provider # 5-115. This program is approved for 1.5 hours of continuing nursing education.
Educational Review Systems is also approved for nursing continuing education by the state of California, the state of Florida and the District of Columbia.
Course release date: 9/19/2020
Course expires: 9/19/2022
|Activity Number||Credit Amount||Accreditation Period|
|0535-0000-20-009-H01-P||0.15 CEUs||September 16, 2020 - September 16, 2023|
|0535-0000-20-009-H01-N||1.5 hours of CNE||September 19, 2020 - September 19, 2022|